Overcoming Insurance Preauthorization Delays and Denials: A Patient Guide to Faster Blood Cancer Care
Insurance delays and denials can stand in the way of timely blood cancer treatment. In this webinar, Ann Chenoweth, a multiple myeloma patient and HealthTree financial coach, shares how she successfully challenged denials, reclaimed thousands of dollars, and kept her care moving forward. Alongside Diahanna Vallentine, HealthTree’s Financial Advocacy Program Manager, you’ll learn step-by-step strategies for understanding denials, gathering medical team support, filing effective appeals, escalating cases, and staying organized so you can take control of the process.
Cynthia introduces the agenda and our featured speaker Diahanna Vallentine and Coach Ann
Diahanna and Ann talk about insurance delays and denials
Come with your questions and we will answer them!
Cynthia Cahoon, RN
Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.
Diahanna Vallentine
Diahanna is the Financial Program Manager for the HealthTree Foundation. She specializes in providing financial help, resources and education for blood cancer patients. As a professional financial consultant and former caregiver of her husband who was diagnosed with multiple myeloma, Diahanna perfectly understands the financial issues facing blood cancer patients.
Ann Chenoweth
Ann was diagnosed at 64 in August, 2022 after her primary care physician ordered a urinalysis during her annual physical. It was abnormal and she quickly referred Ann to a Myeloma specialist/hematologist Though she had no symptoms at all and was very active, Ann was diagnosed with Stage 3 Myeloma and AL Amyloidosis. She had an ASCT in January 2023 and is currently receiving Revlimid and Dara for maintenance therapy. She has continued to be very active: traveling to Europe; hiking in the mountains; playing tennis; and doing reformer pilates all at the same intensity/frequency as before her diagnosis. It was important to her to stay active throughout her diagnosis and treatment. She was playing tennis 5 weeks after ASCT, and back to league play in 2 months. She has received tremendous value from HealthTree coaches and is passionate about paying it forward and wants to support others in their myeloma journey.